Category: Disorders & Diseases

Disorders & Diseases

ATS Initiative for OSA Diagnosis in Primary Care

The project from the American Thoracic Society aims to reduce the high rate of undiagnosed sleep disorders by partnering with primary care providers.

Disorders & Diseases

Duchenne Muscular Dystrophy Cell Therapy Preserves Heart, Muscle Function

Results from the HOPE-3 trial found that an investigational cell therapy called deramiocel preserved heart and muscle function in boys and young men with Duchenne muscular dystrophy (DMD).

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

Diabetes Test May Misdiagnose Patients With Sickle Cell Trait

A standard laboratory assay significantly underestimates blood sugar levels in people with sickle cell trait, potentially leading to widespread underdiagnosis of diabetes.

Infectious Diseases

Cancer Vaccine Platform Uses COVID-19 Immune Memory to Fight Tumors

Researchers developed a system that redirects pre-existing antiviral signals to help the immune system recognize and attack cancer cells.

Critical Care

PCV-VG Ventilation Mode Improved Lung Mechanics

Pressure control-volume guarantee (PCV-VG) ventilation improved intraoperative respiratory mechanics but did not significantly reduce postoperative pulmonary complications compared with conventional volume control ventilation in patients undergoing emergency abdominal surgery.

Cardiopulmonary & Thoracic

FDA Approves Zidesamtinib for Specific Type of Lung Cancer

Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.

Sleep Medicine

FDA Clears HoneyNaps Ai Software for Sleep Apnea Analysis

The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.